Symptomtext
This case involves a 5 weeks and 5 days old female patient who was vaccinated with a dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] (Product administered to patient of inappropriate age). The patient's medical history, medical treatment(s), past vaccination(s) and family history were not provided. Concomitant medications included ROTAVIRUS VACCINE LIVE ORAL 1V (ROTARIX) for prophylactic vaccination. On 23-Nov-2021, the patient received a 0.5 ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE produced by Sanofi Pasteur (lot number: UJ474AA and expiry date: 09-Jul-2022) via intramuscular route in the left thigh for prophylactic vaccination. It was a case of actual medication error due to inappropriate age at vaccine administration (latency same day). It was reported "Physician states a dose of PENTACEL was administered to a patient on 23Nov2021, and it was realized the patient was just under 6 weeks old. Physician is looking for information on how to handle, and if there are any issues as the patient will be turning 6 weeks old soon. The physician reported that a patient received a dose of PENTACEL at 5 weeks and 5 days old. The caller would like to know if this is considered a valid dose and whether it should be repeated". No adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.